메뉴 건너뛰기




Volumn 46, Issue 4, 2005, Pages 266-269

Bupropion-induced subacute cutaneous lupus erythematosus

Author keywords

Drug reaction; Photosensitivity

Indexed keywords

AMFEBUTAMONE; HYDROCHLOROTHIAZIDE; RO ANTIBODY; SUNSCREEN; TACROLIMUS; ANTIDEPRESSANT AGENT; IMMUNOSUPPRESSIVE AGENT;

EID: 33644845350     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00199.x     Document Type: Article
Times cited : (31)

References (14)
  • 2
    • 0027514497 scopus 로고
    • Subacute cutaneous lupus erythematosus
    • David-Bajar KM. Subacute cutaneous lupus erythematosus. J. Invest. Dermatol. 1993 100 : 2S 8S.
    • (1993) J. Invest. Dermatol. , vol.100
    • David-Bajar, K.M.1
  • 3
    • 0034855867 scopus 로고    scopus 로고
    • Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: A report of 5 cases
    • Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch. Dermatol. 2001 137 : 1196 8.
    • (2001) Arch. Dermatol. , vol.137 , pp. 1196-8
    • Callen, J.P.1    Hughes, A.P.2    Kulp-Shorten, C.3
  • 5
    • 0035907629 scopus 로고    scopus 로고
    • Bupropion-induced hypersensitivity reactions
    • 650. 1.
    • Benson E. Bupropion-induced hypersensitivity reactions. Med. J. Aust. 2001 174 : 650 1.
    • (2001) Med. J. Aust. , vol.174
    • Benson, E.1
  • 8
    • 0038578393 scopus 로고    scopus 로고
    • Reactive metabolites and adverse drug reactions: Clinical considerations
    • Knowles SR, Shaprio LE, Shear NH. Reactive metabolites and adverse drug reactions: clinical considerations. Clin. Rev. Allergy Immunol. 2003 24 : 229 38.
    • (2003) Clin. Rev. Allergy Immunol. , vol.24 , pp. 229-38
    • Knowles, S.R.1    Shaprio, L.E.2    Shear, N.H.3
  • 10
    • 0036064802 scopus 로고    scopus 로고
    • Generalized pustular and erythrodermic psoriasis associated with bupropion treatment
    • Cox NH, Gordon PM, Dodd H. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br. J. Dermatol. 2002 146 : 1061 3.
    • (2002) Br. J. Dermatol. , vol.146 , pp. 1061-3
    • Cox, N.H.1    Gordon, P.M.2    Dodd, H.3
  • 11
    • 0038206443 scopus 로고    scopus 로고
    • Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration
    • Bagshaw SM, Cload B, Gilmour J, Leung ST, Bowen TJ. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Ann. Allergy Asthma Immunol. 2003 90 : 572 5.
    • (2003) Ann. Allergy Asthma Immunol. , vol.90 , pp. 572-5
    • Bagshaw, S.M.1    Cload, B.2    Gilmour, J.3    Leung, S.T.4    Bowen, T.J.5
  • 12
    • 2942518503 scopus 로고    scopus 로고
    • Flare of cutaneous lupus erythematosus induced by bupropion
    • Jumez N, Bereure O, Bessis D, Guillot B. Flare of cutaneous lupus erythematosus induced by bupropion. Dermatology 2004 208 : 362.
    • (2004) Dermatology , vol.208 , pp. 362
    • Jumez, N.1    Bereure, O.2    Bessis, D.3    Guillot, B.4
  • 13
    • 0031894796 scopus 로고    scopus 로고
    • Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: Diagnostic criteria and therapeutic implications
    • Chlebus E, Wolska H, Blaszczyk M, Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J. Am. Acad. Dermatol. 1999 40 : 405 12.
    • (1999) J. Am. Acad. Dermatol. , vol.40 , pp. 405-12
    • Chlebus, E.1    Wolska, H.2    Blaszczyk, M.3    Jablonska, S.4
  • 14
    • 33645006102 scopus 로고    scopus 로고
    • Cutaneous lupus erythematosus: A personal approach to management
    • in press.).
    • Callen J. Cutaneous lupus erythematosus: A personal approach to management. Australas J. Dermatol. 2006 47 (in press).
    • (2006) Australas J. Dermatol. , vol.47
    • Callen, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.